JP3004758B2 - Processed starch with excellent binding and disintegration properties - Google Patents

Processed starch with excellent binding and disintegration properties

Info

Publication number
JP3004758B2
JP3004758B2 JP3085426A JP8542691A JP3004758B2 JP 3004758 B2 JP3004758 B2 JP 3004758B2 JP 3085426 A JP3085426 A JP 3085426A JP 8542691 A JP8542691 A JP 8542691A JP 3004758 B2 JP3004758 B2 JP 3004758B2
Authority
JP
Japan
Prior art keywords
starch
shows
physical properties
modified starch
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP3085426A
Other languages
Japanese (ja)
Other versions
JPH04318001A (en
Inventor
悦雄 鎌田
末男 長友
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Original Assignee
Asahi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Corp filed Critical Asahi Kasei Corp
Priority to JP3085426A priority Critical patent/JP3004758B2/en
Publication of JPH04318001A publication Critical patent/JPH04318001A/en
Application granted granted Critical
Publication of JP3004758B2 publication Critical patent/JP3004758B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、医薬品に利用される結
合性、崩壊性に優れた加工澱粉、および該加工澱粉を含
有する製剤組成物に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a modified starch having excellent binding and disintegration properties and a pharmaceutical composition containing the modified starch.

【0002】[0002]

【従来の技術】結合性、崩壊性、増量作用を持った医薬
品添加剤として、澱粉類は、入手の容易さ、天然物であ
り昔から使用されてきたことによる安心感などから、汎
用されてきた。澱粉類は、生澱粉、物理的に変性させた
加工澱粉、化学的に変性させた化工澱粉の3種に分かれ
る。このなかでも加工澱粉は、糊化の程度を変えること
によって、いろいろな物理化学的な性質が発現するこ
と、低価格であること、化学的には全く生澱粉と同じた
め、薬物との反応性がほとんどないこと、などから汎用
されている。生澱粉を水に懸濁させ、沸騰するまで加熱
して澱粉糊とし、湿式造粒用の結合剤として使用するこ
とは、最も古くからの加工澱粉の利用と言えるが、それ
以外にも種々の加工澱粉が提案されている。
2. Description of the Related Art Starches have been widely used as pharmaceutical additives having binding, disintegrating, and bulking effects, because of their ease of availability and the sense of security provided by natural products that have been used for a long time. Was. Starches are classified into three types: raw starch, physically modified processed starch, and chemically modified modified starch. Among these, processed starch exhibits various physicochemical properties by changing the degree of gelatinization, is inexpensive, and chemically chemically the same as raw starch, so it does not react with drugs. It is widely used because there is almost no. Suspending raw starch in water, heating it to boiling to form starch paste, and using it as a binder for wet granulation can be said to be the oldest processed starch use. Modified starch has been proposed.

【0003】特公昭46−21471号公報に記載の加
工澱粉は、生澱粉を約20〜50重量%の水分含量と
し、差動ロール製粉機などで、20〜50℃の温度でコ
ンパクト化、乾燥、粉砕することにより得られるもの
で、約4〜40重量%の範囲で冷水に溶解性を示し、そ
の乾燥物質の膨潤力は約2.5〜12を基準とし、自由
密度は約0.5〜0.7g/mlであり、水分は総重量
に対して約9〜16%である。
[0003] The processed starch described in JP-B-46-21471 has a raw starch content of about 20 to 50% by weight, and is compacted at a temperature of 20 to 50 ° C by a differential roll mill and dried. It is obtained by pulverization, shows solubility in cold water in the range of about 4 to 40% by weight, the swelling power of the dry substance is about 2.5 to 12, and the free density is about 0.5. 0.70.7 g / ml and the water content is about 9-16% of the total weight.

【0004】特公昭59−47600号公報に記載の加
工澱粉は、生澱粉をスラリー状とし、50℃以上であっ
て、かつ糊化開始温度を約10℃上回る温度以下で加熱
することで、生澱粉の外殻薄膜構造を破壊することなく
膨潤させ、次いで乾燥することによって得られるもので
あって、その嵩密度が0.25g/cc以上、冷水可溶
分が10重量%未満、膨潤容積が約3〜15ml/g、
保水力が約2以上である。
The modified starch described in Japanese Patent Publication No. 59-47600 is prepared by converting raw starch into a slurry, and heating the raw starch at a temperature of 50 ° C. or more and a temperature not exceeding about 10 ° C. above the gelatinization start temperature. The starch is obtained by swelling without destroying the outer shell thin film structure and then drying, having a bulk density of 0.25 g / cc or more, a cold water soluble content of less than 10% by weight, and a swelling volume of About 3 to 15 ml / g,
Water retention capacity is about 2 or more.

【0005】特開昭58−32828号公報に記載の加
工澱粉は、生澱粉を糊化、冷却、次いで乾燥することに
より得られるものであって、膨潤度が3.0〜6.0で
ある。特開昭60−233019号公報に記載の加工澱
粉は、糊化温度以下の温度で、澱粉を酸、アルカリ、及
び(または)α−アミラーゼ酵素で処理して得た冷水溶
性粒状澱粉より導かれるものである。
[0005] The modified starch described in JP-A-58-32828 is obtained by gelatinizing, cooling, and then drying raw starch, and has a swelling degree of 3.0 to 6.0. . The processed starch described in Japanese Patent Application Laid-Open No. 60-230319 is derived from a cold water-soluble granular starch obtained by treating starch with an acid, an alkali and / or an α-amylase enzyme at a temperature below the gelatinization temperature. Things.

【0006】また、市販品としてスターチ1500(日
本カラコン(株)製)、PCS(旭化成工業(株)製)
といった部分アルファー化澱粉がある。
[0006] Starch 1500 (manufactured by Nippon Colorcon Co., Ltd.) and PCS (manufactured by Asahi Kasei Kogyo Co., Ltd.) are commercially available.
And partially pregelatinized starch.

【0007】[0007]

【発明が解決しようとする課題】しかし、特公昭46−
21471号公報に記載の加工澱粉は、直接打錠法によ
り錠剤に成形する際の結合性には優れているが、錠剤を
水中で崩壊する力に乏しかった。また、特公昭59−4
7600号公報、特開昭58−32828号公報に記載
の加工澱粉は、錠剤、顆粒剤、カプセル剤に配合した場
合の崩壊性には優れているが、直接打錠法に用いた場合
の結合性に乏しいため、多量に配合することができず、
また、他の結合剤を併用する必要があった。また、特開
昭60−233019号公報に記載の加工澱粉は、直接
圧縮法または乾式顆粒圧縮法に使用される錠剤用結合剤
として有効であるが、錠剤の崩壊性、特に高成形圧で製
錠した場合の錠剤の崩壊性を損なうと言う欠点があっ
た。また、市販品について述べると、スターチ1500
は、直接打錠法に用いると結合性を示すが、錠剤の崩壊
時間が遅延するという欠点があった。また、PCSは、
錠剤、顆粒剤に配合すると、加工澱粉として最も優れた
崩壊性を示すが、直接打錠用の結合剤としての機能はほ
とんどなかった。
[Problems to be solved by the invention]
The processed starch described in Japanese Patent No. 21471 has excellent binding properties when formed into tablets by the direct compression method, but has a poor ability to disintegrate tablets in water. In addition, Japanese Patent Publication No. 59-4
The modified starch described in JP-A-7600 and JP-A-58-32828 has excellent disintegratability when incorporated into tablets, granules and capsules, but binds when used in the direct compression method. Because of poor properties, it can not be blended in large quantities,
In addition, it was necessary to use another binder in combination. Further, the processed starch described in JP-A-60-2333019 is effective as a binder for tablets used in a direct compression method or a dry granulation compression method, but is manufactured under the disintegration property of tablets, especially at high molding pressure. There is a drawback that the disintegration of the tablet is impaired when tableted. As for commercially available products, Starch 1500
Shows a binding property when used in the direct compression method, but has a drawback that the disintegration time of the tablet is delayed. PCS also
When incorporated into tablets and granules, it exhibited the best disintegration properties as a modified starch, but had little function as a binder for direct compression.

【0008】以上のように、これまでの加工澱粉では、
直接打錠法または乾式顆粒法に用いたときに、結合性と
崩壊性の機能を同時に満足するものはなく、両機能を併
せ持つ加工澱粉が望まれていた。
[0008] As described above, in conventional processed starch,
When used in the direct tableting method or the dry granulation method, none of them satisfy the functions of binding and disintegration at the same time, and a modified starch having both functions has been desired.

【0009】[0009]

【問題点を解決するための手段、作用】本発明者は、鋭
意検討の結果、生澱粉を水分の存在下、加熱処理するこ
とにより得られる、含水率が8〜15%、冷水可溶分が
10%未満、膨潤容積が5〜15ml/gである加工澱
粉が、直接打錠法または乾式顆粒圧縮法に用いたとき
に、結合性、崩壊性の両機能を併せ持つことを見いだ
し、本発明に至った。
Means for Solving the Problems and Action As a result of intensive studies, the present inventor has found that a raw starch obtained by heat-treating raw starch in the presence of moisture has a water content of 8 to 15% and a cold water soluble component. It has been found that a modified starch having a ratio of less than 10% and a swelling volume of 5 to 15 ml / g has both binding and disintegrating functions when used in a direct compression method or a dry granulation compression method. Reached.

【0010】即ち、本発明は、生澱粉を水分の存在下、
加熱処理することにより得られる加工澱粉であって、含
水率が8〜15%、冷水可溶分が10%未満、膨潤容積
が5〜15ml/gであって、実質的に澱粉粒子が破壊
されることなく澱粉の粒子形態を維持しており、非複屈
折性を示す粒子が複屈折性を示す粒子より多く存在する
ことを特徴とする結合性、崩壊性に優れる加工澱粉、お
よび該加工澱粉を含有する製剤組成物に関する。本発明
の加工澱粉は、特定された含水率、冷水可溶分、膨潤容
積を持ち、結合性に優れるので、直接打錠法あるいは乾
式顆粒圧縮法を用いて粉体あるいは顆粒を錠剤へ圧縮す
る場合に、硬度の高い錠剤を得ることができる。また、
乾式顆粒法を用いて顆粒を作ると、粉化の小さい、強度
の高い顆粒ができる。また、同時に崩壊性にも優れるの
で、該加工澱粉を含有した製剤を体内に投与したとき
に、加工澱粉が水を吸収して膨潤するため、製剤は迅速
な崩壊を示し、薬物は速やかに溶出する。また他の結晶
セルロース、乳糖などの結合剤と比べると、崩壊性がよ
いことはもちろん薬物に対する安定性が高いこと、結合
性・崩壊性の両機能を持つので処方を簡潔にできること
などにより品質設計が容易になる利点がある。
That is, the present invention provides a method for preparing raw starch in the presence of moisture.
Processed starch obtained by heat treatment, having a water content of 8 to 15%, a soluble component of cold water of less than 10%, a swelling volume of 5 to 15 ml / g, and substantially destroying starch particles.
The starch particle morphology is maintained without being
More particles exhibiting foldability than particles exhibiting birefringence
The present invention relates to a modified starch excellent in binding property and disintegration, and a pharmaceutical composition containing the modified starch. The modified starch of the present invention has a specified water content, cold water soluble content, swelling volume, and excellent binding properties, so that powders or granules are compressed into tablets using a direct compression method or a dry granule compression method. In this case, a tablet having high hardness can be obtained. Also,
When granules are formed using the dry granulation method, granules with low powdering and high strength can be obtained. At the same time, the disintegration is also excellent, so that when the preparation containing the modified starch is administered into the body, the modified starch absorbs water and swells, so that the preparation shows rapid disintegration and the drug is rapidly dissolved. I do. In addition, compared to other binders such as microcrystalline cellulose and lactose, it has good disintegration properties as well as high drug stability, and it has both binding and disintegration functions, so quality design can be simplified. Has the advantage of being easier.

【0011】以下本発明について詳細に説明する。本発
明でいう加工澱粉は、生澱粉を水分の存在下、加熱処理
することにより得られるものであって、含水率が8〜1
5%、好ましくは10〜15%、冷水可溶分が10%未
満、好ましくは5%未満、膨潤容積が5〜15ml/
g、好ましくは5〜11ml/gであることが必要であ
る。また好ましくは、その嵩密度は0.35〜0.65
g/ml、特に好ましくは0.4〜0.6g/ml、1
00メッシュ(目開き150μm)留分が50%以下、
特に好ましくは30%以下である。
Hereinafter, the present invention will be described in detail. The processed starch referred to in the present invention is obtained by subjecting raw starch to heat treatment in the presence of moisture, and has a water content of 8 to 1%.
5%, preferably 10-15%, cold water soluble less than 10%, preferably less than 5%, swelling volume 5-15 ml /
g, preferably 5 to 11 ml / g. Also preferably, the bulk density is from 0.35 to 0.65
g / ml, particularly preferably 0.4 to 0.6 g / ml, 1
00 mesh (aperture 150 μm) fraction is 50% or less,
It is particularly preferably at most 30%.

【0012】ここでいう加工澱粉とは、水分の存在下で
加熱処理し、乾燥することにより得られるものであっ
て、化学的変性を施したものは含まない。また、本発明
の加工澱粉を水中に投入して顕微鏡で観察するとき、ほ
とんどの粒子が、膨潤してはいるものの澱粉の粒子形態
は維持されており、個々の粒子は識別可能である。個々
の粒子が識別できないほど破壊された非複屈折性の澱粉
では、冷水可溶分が増し、後述のように好ましくない。
また偏光顕微鏡で観察すると、非複屈折性を示す粒子の
ほうが複屈折性を示す粒子より多く存在する。
The term "modified starch" as used herein refers to one obtained by heating and drying in the presence of moisture, and does not include chemically modified starch. When the modified starch of the present invention is put into water and observed with a microscope, most of the particles are swollen, but the particle morphology of the starch is maintained, and the individual particles are identifiable. Non-birefringent starch, in which the individual particles are destroyed so as to be indistinguishable, increases the amount of soluble components in cold water, which is undesirable as described later.
When observed with a polarizing microscope, more particles exhibit non-birefringence than particles exhibit birefringence.

【0013】加工澱粉の含水率が8%以下では、澱粉の
可塑性が小さくなると同時に、圧縮した後の弾性回復が
大きくなるために、結合性が小さくなる。含水率が15
%以上では、澱粉の可塑性は大きくなるのだが、圧縮に
より粒子内に含まれる水分が、粒子表面ににじみ出すた
めか、逆に結合性は小さくなるので好ましくない。好ま
しくは10〜15%である。冷水可溶分が10%以上の
加工澱粉では、吸水して溶解する成分が多いため、錠剤
に用いた場合、崩壊液に溶解し粘着性となるため、錠剤
内部への液の浸透が遅くなるので、崩壊が遅延し好まし
くない。好ましくは7%未満である。膨潤容積が5ml
/g未満では、吸水による膨潤が小さいため、錠剤を崩
壊するのに十分な力を与えられない。膨潤容積が15m
l/g以上の加工澱粉を製造するには、糊化の程度を高
くする必要があり、同時に冷水可溶分も増加してしまう
ので、上限は15ml/gである。好ましくは5〜11
ml/gである。
When the water content of the modified starch is 8% or less, the plasticity of the starch is reduced, and the elastic recovery after compression is increased. 15 moisture content
%, The plasticity of the starch increases, but it is not preferable because the moisture contained in the particles oozes out on the particle surface due to the compression, or conversely, the binding property decreases. Preferably it is 10 to 15%. Processed starch having a cold water soluble content of 10% or more has many components that absorb and dissolve in water, and when used in tablets, dissolves in disintegrating liquid and becomes sticky, slowing the penetration of the liquid into the inside of the tablet. Therefore, the disintegration is undesirably delayed. Preferably it is less than 7%. 5 ml swelling volume
If it is less than / g, the swelling due to water absorption is small, so that a sufficient force to disintegrate the tablet cannot be given. Swelling volume is 15m
In order to produce a processed starch of 1 / g or more, it is necessary to increase the degree of gelatinization, and at the same time, the amount of soluble components in cold water increases, so the upper limit is 15 ml / g. Preferably 5 to 11
ml / g.

【0014】また、加工澱粉の嵩密度が0.35ml/
g以下では軽質になるため、粉体としての流動性が悪く
なる。また、圧縮した後の錠剤が厚くなるという欠点が
ある。嵩密度が0.65g/ml以上では、圧縮時の変
形能が小さくなるため、結合性が小さくなり好ましくな
い。特に好ましくは、0.40〜0.60g/mlであ
る。加工澱粉の100メッシュ留分が50%以上と粒度
が大きいと、製剤間の加工澱粉の含量のばらつきが大き
くなるため、錠剤硬度、崩壊時間のばらつきが大きくな
る。また、錠剤がブロック型の崩壊を示すため、薬物の
溶出が遅くなり好ましくない。特に好ましくは、30%
以下である。
The bulk density of the processed starch is 0.35 ml /
If it is less than g, the powder will be light and the fluidity as a powder will be poor. In addition, there is a disadvantage that the tablet after compression becomes thick. If the bulk density is 0.65 g / ml or more, the deformability at the time of compression becomes small, and the bonding property becomes small, which is not preferable. Particularly preferably, it is 0.40 to 0.60 g / ml. If the particle size of the modified starch is as large as 50% or more, the dispersion of the modified starch content among the preparations is large, and the dispersion of tablet hardness and disintegration time is large. In addition, since the tablet shows block-type disintegration, the dissolution of the drug is delayed, which is not preferable. Particularly preferably, 30%
It is as follows.

【0015】本発明の加工澱粉の製造方法について述べ
る。本製造方法は、生澱粉を水分の存在下加熱処理する
ことにより、粒子形態を破壊することなく、澱粉粒子を
膨潤させ、次いで乾燥し、必要ならば粉砕することから
なる方法である。加熱時の生澱粉の含水率は、生澱粉乾
燥重量に対して約50%以上であればよいが、生澱粉の
糊化に要する温度は、澱粉が湿潤した程度の含水率で
は、含まれる水分が少ないほど高温となるので、含水率
が100%以上であって、ペースト状あるいはスラリー
状を呈する状態で加熱処理するほうがエネルギーコスト
的に有利であり好ましい。また、この状態で加熱したほ
うが、全ての粒子に対して均一な加熱ができるので好ま
しい。また、加熱温度については、糊化開始温度が澱粉
種、粒径、産地、精製条件、生澱粉の含水率などにより
変化するので特定は困難であるが、ペースト状あるいは
スラリー状においては、澱粉種に特有の糊化開始温度を
10℃上回る温度以下の温度で処理すると良い。ちなみ
に「澱粉科学ハンドブック」(二国二郎監修、朝倉書
店、1977、p36)によれば、フォトペースト法に
よる主な澱粉の糊化開始温度は、トウモロコシ;66.
8℃、馬鈴薯;61.0℃、タピオカ;65.4℃、甘
藷;65.8℃である。
The method for producing the modified starch of the present invention will be described. This production method is a method comprising subjecting raw starch to heat treatment in the presence of moisture to swell the starch particles without destroying the particle morphology, followed by drying and, if necessary, grinding. The moisture content of the raw starch at the time of heating may be about 50% or more based on the dry weight of the raw starch. However, the temperature required for gelatinization of the raw starch is such that the moisture content is such that the starch is wet. The smaller the amount, the higher the temperature. Therefore, it is preferable to perform heat treatment in a state of having a water content of 100% or more and in a paste or slurry state, because it is advantageous in terms of energy cost. Heating in this state is preferable because all particles can be uniformly heated. In addition, it is difficult to specify the heating temperature because the gelatinization start temperature varies depending on the type of starch, the particle size, the place of production, the purification conditions, the water content of raw starch, and the like. It is preferable to treat at a temperature not higher than 10 ° C. which is higher than the gelatinization start temperature peculiar to. Incidentally, according to the "Starch Science Handbook" (supervised by Jiro Fukukoku, Asakura Shoten, 1977, p. 36), the main gelatinization start temperature of starch by the photopaste method is corn;
8 ° C., potato; 61.0 ° C., tapioca; 65.4 ° C., sweet potato; 65.8 ° C.

【0016】次に加熱方法であるが、澱粉を5〜50%
程度含む水懸濁液をつくった後、ジャケット付き攪拌槽
でジャケットに温水を通して昇温する方法、あるいは澱
粉懸濁液を攪拌しながら、直接温水を投入し昇温する方
法、あるいは温水の代わりに蒸気を吹き込む方法、ある
いは澱粉懸濁液をプレ−ト式熱交換機を通して加熱する
方法などがある。もっと澱粉の含有量を高めて、密閉状
態で高温加熱しても構わない。加熱時間は数10秒から
1時間程度まで自由に選び得るが、ペースト状あるいは
スラリー状で、糊化開始温度を10℃近く上回った温度
で長時間加熱すると、糊化が進みすぎ澱粉の粒子形態が
破壊され、冷水可溶分が増加するので好ましくない。所
定の加熱が終わった後は、糊化開始温度以下に冷却する
工程を加える方が品質が一定するので、好ましい。加熱
前あるいは加熱中あるいは加熱後に、可溶性澱粉、デキ
ストリン、アルファー化澱粉を、澱粉中の冷水可溶分が
10%を越えないように添加するのは構わない。また、
加熱中あるいは加熱後に、澱粉中の冷水可溶分が10%
を越えない程度に、攪拌、磨砕などを加えることも構わ
ない。次に乾燥方法であるが、ペースト状あるいはスラ
リー状のものを瞬時に乾燥可能な噴霧乾燥機、フラッシ
ュドライヤーなどが最適である。固形分濃度が高い場合
には、水を添加してから上記方法で乾燥してもよいが、
糊化開始温度より低い温度でそのまま乾燥することも可
能である。
Next, the heating method is as follows.
After making a water suspension containing water, a method of raising the temperature by passing warm water through the jacket in a jacketed stirring tank, or a method of directly adding hot water while stirring the starch suspension and raising the temperature, or instead of warm water There are a method of blowing steam and a method of heating a starch suspension through a plate heat exchanger. The starch content may be further increased, and the mixture may be heated at a high temperature in a closed state. The heating time can be freely selected from several tens of seconds to about one hour, but if the paste or slurry is heated for a long time at a temperature approximately 10 ° C higher than the gelatinization start temperature, gelatinization will progress too much and the starch particle form Is destroyed, and the amount of soluble components in cold water increases, which is not preferable. After the completion of the predetermined heating, it is preferable to add a step of cooling the mixture to a temperature lower than the gelatinization start temperature because the quality is constant. Before, during, or after heating, the soluble starch, dextrin, and pregelatinized starch may be added so that the amount of cold water-soluble components in the starch does not exceed 10%. Also,
During or after heating, the cold water soluble content of starch is 10%
Stirring, grinding, etc. may be added to such an extent that does not exceed. Next, as for the drying method, a spray drier or a flash drier which can instantaneously dry a paste or slurry is optimal. If the solid content concentration is high, it may be dried by the above method after adding water,
It is also possible to dry as it is at a temperature lower than the gelatinization start temperature.

【0017】本発明の加工澱粉の原料となる生澱粉につ
いて述べる。生澱粉としては、コーン、小麦、米などの
地上澱粉、ポテト、タピオカ、甘藷などの地下茎澱粉な
どがあげられるが、いずれも使用し得る。また、2つ以
上の生澱粉の混合物を用いても構わない。地下茎澱粉は
温度によって糊化の程度が大きく変化するので、条件を
厳密にコントロール、例えば所定の温度に達したら即座
に冷却することによって糊化度をコントロールすれば使
用可能である。他には、例えばプレート式熱交を使用す
る方法を用いれば製造は容易である。
Raw starch which is a raw material of the processed starch of the present invention will be described. Examples of the raw starch include ground starch such as corn, wheat and rice, and underground stem starch such as potato, tapioca and sweet potato, and any of them can be used. Further, a mixture of two or more raw starches may be used. Since the degree of gelatinization of the rhizome starch varies greatly depending on the temperature, it can be used if the degree of gelatinization is controlled by strictly controlling the conditions, for example, by cooling immediately after reaching a predetermined temperature. Otherwise, the production is easy if, for example, a method using plate heat exchange is used.

【0018】次に本発明の加工澱粉を用いた製剤組成物
について述べる。本発明の製剤組成物は、錠剤、顆粒剤
あるいは顆粒を充填したカプセル剤である。従来の加工
澱粉を使用した場合と比べて、錠剤(顆粒)硬度、崩壊
時間(ひいては薬物の溶出速度)共に優れた錠剤、顆粒
剤、カプセル剤となる。また、結晶セルロースや乳糖を
配合すると安定性の悪い薬物の場合に、加工澱粉を使用
すると安定性の良い製剤となる。また、ここでいう製剤
には、下記方法で作られる錠菓、機能性食品などの錠
剤、顆粒剤、カプセル剤の形状をした食品類も含まれる
と考えるべきである。加工澱粉の添加量は、薬物の配合
量、製剤の大きさにより影響されるが、結合性と崩壊性
の両機能を満足するには2〜70%程度である。好まし
くは5〜50%程度である。また、他の添加剤として
は、結晶セルロース、乳糖、コーンスターチなど通常用
いられる添加剤が配合できる。
Next, a pharmaceutical composition using the modified starch of the present invention will be described. The pharmaceutical composition of the present invention is a tablet, a granule or a capsule filled with granules. Tablets, granules, and capsules that are superior in both tablet (granule) hardness and disintegration time (and, consequently, drug dissolution rate) as compared with the case of using conventional processed starch. In addition, in the case of a drug with poor stability when crystalline cellulose or lactose is blended, the use of a modified starch results in a formulation with good stability. In addition, it should be considered that the formulation herein includes foods in the form of tablets, granules, and capsules such as tablets and functional foods produced by the following method. The added amount of the processed starch is affected by the amount of the drug and the size of the preparation, but is about 2 to 70% to satisfy both functions of binding and disintegration. Preferably, it is about 5 to 50%. As other additives, commonly used additives such as crystalline cellulose, lactose and corn starch can be blended.

【0019】次に製剤組成物の製法について述べる。ま
ず、錠剤についてであるが、一種以上の薬物、加工澱粉
および必要であれば他の添加剤から成る粉体を混合し、
そのまま圧縮する、いわゆる直接打錠法あるいは上記粉
体を板状あるいは錠剤状に圧縮した後解砕し、顆粒を作
成し、さらに顆粒を圧縮する乾式顆粒圧縮法があげられ
る。顆粒剤は、上記方法で顆粒を作り、必要ならば篩分
する方法により作られる。カプセル剤は、上記顆粒をカ
プセルに充填して作られる。また、錠剤、顆粒をフィル
ムコーティングしたり糖衣掛けするのは自由である。
Next, a method for producing the pharmaceutical composition will be described. First, for tablets, mixing a powder consisting of one or more drugs, modified starch and, if necessary, other additives,
A direct compression method, which is compression as it is, or a dry granule compression method in which the powder is compressed into a plate or tablet and then crushed to prepare granules and further compress the granules. Granules are prepared by a method in which granules are prepared by the above method and, if necessary, sieved. Capsules are made by filling the granules into capsules. In addition, tablets and granules are free to be film-coated or sugar-coated.

【0020】[0020]

【実施例】以下、実施例により本発明を説明する。な
お、加工澱粉と錠剤の物性評価方法は下記の通りであ
る。加工澱粉 ・含水率(%) 試料10gを105℃で6時間乾燥した時の減量を10
で除し、求める。
The present invention will be described below with reference to examples. In addition, the physical property evaluation method of a processed starch and a tablet is as follows. Processed starch / moisture content (%) 10 g of sample was dried at 105 ° C. for 6 hours, and the weight loss was
Divide by and ask.

【0021】・冷水可溶分(%) 25℃の純水297mlに試料3g(乾燥物換算)を加
え、エースホモジナイザー(日本精機(株)製)を用
い、1500rpmで2分間攪拌する。次に得られた懸
濁液を濾紙を用いて濾過する。濾液30mlを取り、1
05℃で恒量になるまで乾燥する。乾燥物重量を100
0倍し、用いた試料重量で除した値を冷水可溶分とす
る。
Cold water soluble matter (%) 3 g of a sample (in terms of dry matter) is added to 297 ml of pure water at 25 ° C., and the mixture is stirred at 1500 rpm for 2 minutes using an ace homogenizer (manufactured by Nippon Seiki Co., Ltd.). Next, the obtained suspension is filtered using filter paper. Take 30 ml of the filtrate,
Dry to constant weight at 05 ° C. Dry matter weight 100
The value obtained by multiplying by 0 and dividing by the weight of the sample used is defined as a soluble component in cold water.

【0022】・膨潤容積(ml/g) 25℃の純水約80gに、試料5gを加え分散させる。
分散液を共栓付き100mlメスシリンダーに入れ、純
水を加え100mlとする。密栓し24時間静置後、膨
潤した試料容積を5で除し膨潤容積とする。 ・嵩密度(g/ml) 100mlメスシリンダーに試料30gを少しずつ流し
込んだ時の試料の容積を測定する。30gを試料容積で
除し嵩密度とする。
Swelling volume (ml / g) 5 g of a sample is added and dispersed in about 80 g of pure water at 25 ° C.
The dispersion is placed in a 100 ml graduated cylinder with a stopper, and pure water is added to make 100 ml. After sealing and allowing to stand for 24 hours, the swollen sample volume is divided by 5 to obtain the swollen volume. -Bulk density (g / ml) Measure the volume of the sample when 30 g of the sample is poured little by little into a 100 ml measuring cylinder. 30 g is divided by the sample volume to obtain the bulk density.

【0023】・100メッシュ留分(%) 柳本製作所(株)製ロータップ式篩分機により、100
メッシュ篩(目開き150μm)を装着し、試料30g
を30分間篩分した後の篩上の残留分である。錠剤 ・硬度(kg) フロイント産業(株)製シュロインガー硬度計で錠剤の
径方向に力を加え、破壊したときの力で表す。繰り返し
数は20で、その平均値をとる。
100-mesh fraction (%) A 100-mesh fraction (100%) was measured using a low tapping type sieve manufactured by Yanagimoto Seisakusho Co., Ltd.
A mesh sieve (150 μm opening) is attached, and the sample is 30 g
Is the residue on the sieve after sieving for 30 minutes. Tablet hardness (kg) Expressed as the force at the time of breaking when a force is applied in the radial direction of the tablet using a Schroinger hardness tester manufactured by Freund Corporation. The number of repetitions is 20, and the average value is taken.

【0024】・崩壊時間(分) 富山産業(株)製崩壊試験機NT−2HSで、崩壊液と
して純水を用いて行った。繰り返し数は6で、その平均
値をとる。なおディスクは使用していない。
Disintegration time (minutes) The disintegration test was performed using a disintegration tester NT-2HS manufactured by Toyama Sangyo Co., Ltd. using pure water as a disintegration liquid. The number of repetitions is 6, and the average value is taken. No disks were used.

【0025】[0025]

【実施例1】コ−ンスタ−チ(日澱化学(株)製)1k
gを60℃の温水7kgに分散させ、このスラリ−を攪
拌しながら、1℃/minの速度で昇温し、68℃にな
るまで加温した後、約20℃の水2kgを加え、熱処理
を止めた。次いで、小型噴霧乾燥機(大川原化工機
(株)製)を用いて、入口温度約160℃、スラリ−供
給速度7kg/hrの条件でスラリ−を噴霧して、加工
澱粉(A)を得た。加工澱粉(A)の物性を表1に示
す。
Example 1 Corn starch (manufactured by Nisse Chemical Co., Ltd.) 1k
g was dispersed in 7 kg of hot water at 60 ° C., and the slurry was heated at a rate of 1 ° C./min while stirring, heated to 68 ° C., and 2 kg of water at about 20 ° C. was added thereto. Stopped. Next, using a small spray dryer (manufactured by Okawara Kakoki Co., Ltd.), the slurry was sprayed under the conditions of an inlet temperature of about 160 ° C. and a slurry supply speed of 7 kg / hr to obtain a processed starch (A). . Table 1 shows the physical properties of the modified starch (A).

【0026】[0026]

【実施例2】噴霧乾燥機の入口温度が約130℃である
こと以外は実施例1と同様に操作し、加工澱粉(B)を
得た。加工澱粉(B)の物性を表1に示す。
Example 2 A modified starch (B) was obtained in the same manner as in Example 1, except that the inlet temperature of the spray dryer was about 130 ° C. Table 1 shows the physical properties of the processed starch (B).

【0027】[0027]

【比較例1】特公昭59−47600号公報に準じた方
法で行った。コ−ンスタ−チ(日澱化学(株)製)1k
gを60℃の温水7kgに分散させ、このスラリ−を攪
拌しながら、1℃/minの速度で昇温し、65℃とし
た後、20分間加温した。次いで、入口温度を約180
℃とする以外は実施例と同様に操作し、加工澱粉(C)
を得た。加工澱粉(C)の物性を表1に示す。
[Comparative Example 1] This was carried out by a method according to Japanese Patent Publication No. 59-47600. Cornstark (manufactured by Nisseki Chemical Co., Ltd.) 1k
g was dispersed in 7 kg of warm water at 60 ° C., and the slurry was heated at a rate of 1 ° C./min while stirring, heated to 65 ° C., and then heated for 20 minutes. Then, the inlet temperature was set to about 180
The same operation as in the example was conducted except that the temperature was changed to ° C.
I got Table 1 shows the physical properties of the processed starch (C).

【0028】[0028]

【比較例2】噴霧乾燥機の入口温度が約115℃である
こと以外は実施例1と同様に操作し、加工澱粉(D)を
得た。加工澱粉(D)の物性を表1に示す。
Comparative Example 2 A modified starch (D) was obtained in the same manner as in Example 1 except that the inlet temperature of the spray dryer was about 115 ° C. Table 1 shows the physical properties of the processed starch (D).

【0029】[0029]

【実施例3】加工澱粉(C)を25℃、75%RHの雰
囲気下にそれぞれ12時間、24時間放置し、加工澱粉
(E)、(F)を得た。加工澱粉(E)、(F)の物性
を表1に示す。
Example 3 The modified starch (C) was left in an atmosphere of 25 ° C. and 75% RH for 12 hours and 24 hours, respectively, to obtain modified starches (E) and (F). Table 1 shows the physical properties of the processed starches (E) and (F).

【0030】[0030]

【比較例3】加工澱粉(C)を実施例3の条件で72時
間放置し、加工澱粉(G)を得た。加工澱粉(G)の物
性を表1に示す。
Comparative Example 3 The modified starch (C) was left under the conditions of Example 3 for 72 hours to obtain a modified starch (G). Table 1 shows the physical properties of the processed starch (G).

【0031】[0031]

【実施例4】65℃になるまで加温すること、噴霧乾燥
機の入口温度を約150℃にすること以外は実施例1と
同様に操作し、加工澱粉(H)を得た。加工澱粉(H)
の物性を表1に示す。
Example 4 A modified starch (H) was obtained in the same manner as in Example 1 except that the temperature was raised to 65 ° C and the inlet temperature of the spray dryer was set to about 150 ° C. Processed starch (H)
Table 1 shows the physical properties of the compound.

【0032】[0032]

【実施例5】72℃になるまで加温すること以外は実施
例4と同様に操作し、加工澱粉(I)を得た。加工澱粉
(I)の物性を表1に示す。
Example 5 A modified starch (I) was obtained in the same manner as in Example 4, except that the temperature was raised to 72 ° C. Table 1 shows the physical properties of the processed starch (I).

【0033】[0033]

【比較例4】63℃になるまで加温すること以外は実施
例4と同様に操作し、加工澱粉(J)を得た。加工澱粉
(J)の物性を表1に示す。
Comparative Example 4 A modified starch (J) was obtained in the same manner as in Example 4 except that the temperature was raised to 63 ° C. Table 1 shows the physical properties of the processed starch (J).

【0034】[0034]

【比較例5】80℃になるまで加温し、1時間保温する
こと以外は実施例4と同様に操作し、加工澱粉(K)を
得た。加工澱粉(K)の物性を表1に示す。
Comparative Example 5 A modified starch (K) was obtained in the same manner as in Example 4 except that the temperature was raised to 80 ° C. and the temperature was maintained for 1 hour. Table 1 shows the physical properties of the processed starch (K).

【0035】[0035]

【実施例6】フェナセチン(山本化学(株)製、微粉)
200部、結晶セルロ−ス(旭化成工業(株)製、アビ
セルPH−101)400部、乳糖(DMV社製、10
0メッシュ)295部、ステアリン酸マグネシウム(太
平化学(株)製)5部に加工澱粉(A)100部を配合
し、常法どおり混合した後、ロ−タリ−打錠機(菊水製
作所(株)製、コレクト12)を用いて、錠剤径8mm
φ、平均錠剤重量200mgの錠剤を得た。錠剤物性を
表2に示す。
Example 6 Phenacetin (fine powder, manufactured by Yamamoto Chemical Co., Ltd.)
200 parts, crystal cellulose (Abicel PH-101, manufactured by Asahi Kasei Corporation), lactose (DMV, 10 parts)
(0 mesh) and 295 parts of magnesium stearate (manufactured by Taihei Chemical Co., Ltd.) were mixed with 100 parts of the processed starch (A) and mixed as usual, followed by a rotary tableting machine (Kikusui Seisakusho Co., Ltd.). 8) tablet diameter using Collect 12)
φ, tablets having an average tablet weight of 200 mg were obtained. Table 2 shows the physical properties of the tablets.

【0036】[0036]

【実施例7】加工澱粉(B)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
Example 7 The same operation as in Example 6 was carried out except that the modified starch (B) was used. Table 2 shows the physical properties of the tablets.

【0037】[0037]

【実施例8】加工澱粉(E)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
Example 8 The same operation as in Example 6 was carried out except that the modified starch (E) was used. Table 2 shows the physical properties of the tablets.

【0038】[0038]

【実施例9】加工澱粉(F)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
Example 9 The same operation as in Example 6 was carried out except that the modified starch (F) was used. Table 2 shows the physical properties of the tablets.

【0039】[0039]

【実施例10】加工澱粉(H)を用いる以外は実施例6
と同様に操作した。錠剤物性を表2に示す。
Example 10 Example 6 except that modified starch (H) was used.
The same operation was performed. Table 2 shows the physical properties of the tablets.

【0040】[0040]

【実施例11】加工澱粉(I)を用いる以外は実施例6
と同様に操作した。錠剤物性を表2に示す。
Example 11 Example 6 except that modified starch (I) was used.
The same operation was performed. Table 2 shows the physical properties of the tablets.

【0041】[0041]

【比較例6】加工澱粉(C)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
Comparative Example 6 The same operation as in Example 6 was carried out except that the modified starch (C) was used. Table 2 shows the physical properties of the tablets.

【0042】[0042]

【比較例7】加工澱粉(D)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
Comparative Example 7 The same operation as in Example 6 was carried out except that the modified starch (D) was used. Table 2 shows the physical properties of the tablets.

【0043】[0043]

【比較例8】加工澱粉(G)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
Comparative Example 8 The same operation as in Example 6 was carried out except that the modified starch (G) was used. Table 2 shows the physical properties of the tablets.

【0044】[0044]

【比較例9】加工澱粉(J)を用いる以外は実施例6と
同様に操作した。錠剤物性を表2に示す。
Comparative Example 9 The same operation as in Example 6 was carried out except that the modified starch (J) was used. Table 2 shows the physical properties of the tablets.

【0045】[0045]

【比較例10】加工澱粉(K)を用いる以外は実施例6
と同様に操作した。錠剤物性を表2に示す。
Comparative Example 10 Example 6 except that modified starch (K) was used.
The same operation was performed. Table 2 shows the physical properties of the tablets.

【0046】[0046]

【比較例11】加工澱粉のかわりにコーンスターチ(C
S、日澱化学(株)製)を用い、実施例6と同様に打錠
する。CSの物性を表1に示し、打錠結果を表2に示
す。
Comparative Example 11 Instead of modified starch, corn starch (C
S, manufactured by Nisset Chemical Co., Ltd.) in the same manner as in Example 6. Table 1 shows the physical properties of CS, and Table 2 shows the results of tableting.

【0047】[0047]

【実施例12】コ−ンスタ−チ1.5kgを60℃の温
水4kgに分散させた後、67℃に昇温する。次いでこ
れをトレイに移し、40℃の熱風乾燥機で水分約12%
になるまで乾燥した後、バンタムミル(ホソカワミクロ
ン社製)で粉砕して、加工澱粉(L)を得た。加工澱粉
(L)の物性を表3に示す。
Example 12 1.5 kg of a constarch was dispersed in 4 kg of hot water at 60 ° C, and the temperature was raised to 67 ° C. Next, transfer this to a tray and use a hot-air dryer at 40 ° C to reduce the water content to about 12%.
After drying until the mixture became ground, it was pulverized with a bantam mill (manufactured by Hosokawa Micron Corporation) to obtain a processed starch (L). Table 3 shows the physical properties of the processed starch (L).

【0048】[0048]

【比較例12】水分約7%になるまで乾燥する以外は、
実施例12と同様に操作し、加工澱粉(M)を得た。加
工澱粉(M)の物性を表3に示す。
[Comparative Example 12] Except for drying to about 7% moisture,
The same operation as in Example 12 was performed to obtain a processed starch (M). Table 3 shows the physical properties of the modified starch (M).

【0049】[0049]

【実施例13】噴霧乾燥を行う前に、バッチ式アトライ
タ10S(三井三池化工機(株)、3mmφのアルミナ
ボ−ル使用)を用いて、500rpmで5分間処理する
以外は、実施例4と同様に操作し、加工澱粉(N)を得
た。加工澱粉(N)の物性を表3に示す。
Example 13 Same as Example 4 except that before spray drying, treatment was performed at 500 rpm for 5 minutes using a batch type attritor 10S (using Mitsui Miike Kakoki Co., Ltd., 3 mmφ alumina ball). To obtain a processed starch (N). Table 3 shows the physical properties of the processed starch (N).

【0050】[0050]

【実施例14】バッチ式アトライタ10Sで、20分間
処理する以外は、実施例13と同様に操作し、加工澱粉
(O)を得た。加工澱粉(O)の物性を表3に示す。
Example 14 A modified starch (O) was obtained in the same manner as in Example 13, except that the treatment was carried out with a batch attritor 10S for 20 minutes. Table 3 shows the physical properties of the processed starch (O).

【0051】[0051]

【比較例13】バッチ式アトライタ10Sで、40分間
処理する以外は、実施例13と同様に操作し、加工澱粉
(P)を得た。加工澱粉(P)の物性を表3に示す。
Comparative Example 13 A modified starch (P) was obtained in the same manner as in Example 13 except that the batch type attritor 10S was used for 40 minutes. Table 3 shows the physical properties of the processed starch (P).

【0052】[0052]

【比較例14】噴霧乾燥を行う前に、バッチ式アトライ
タ10S(3mmφのアルミナボールを使用)を用い
て、500rpmで2分間処理する以外は、比較例1と
同様に操作し、加工澱粉(Q)を得た。加工澱粉(Q)
の物性を表3に示す。
Comparative Example 14 A modified starch (Q) was prepared in the same manner as in Comparative Example 1 except that before spray drying, the mixture was treated at 500 rpm for 2 minutes using a batch type attritor 10S (using 3 mmφ alumina balls). ) Got. Processed starch (Q)
The physical properties of are shown in Table 3.

【0053】[0053]

【実施例15】ポテトスタ−チ(日澱化学(株)製)を
用い、到達温度を62℃とする以外は実施例2と同様に
行い、加工澱粉(R)を得た。加工澱粉(R)の物性を
表3に示す。
Example 15 A modified starch (R) was obtained in the same manner as in Example 2 except that the potato starch (manufactured by Nisseki Chemical Co., Ltd.) was used and the temperature reached was 62 ° C. Table 3 shows the physical properties of the modified starch (R).

【0054】[0054]

【実施例16】噴霧乾燥を行う前に、デキストリン(松
谷化学(株)製、パインデックス−100)をコ−ンス
タ−チ固形分に対して3%添加する以外は、実施例2と
同様に行い、加工澱粉(S)を得た。加工澱粉(S)の
物性を表3に示す。
Example 16 The procedure of Example 2 was repeated, except that dextrin (Paindex-100, manufactured by Matsutani Chemical Co., Ltd.) was added at 3% to the solid content of the corn starch before spray drying. Then, a modified starch (S) was obtained. Table 3 shows the physical properties of the processed starch (S).

【0055】[0055]

【比較例15】特公昭46−21472号公報の技術3
に準じた方法で行った。即ち、コーンスターチに加水
し、水分含量25%とした後、ロールミル(ノリタケカ
ンパニー製、NR−42A)を3回磨砕し、熱風乾燥機
で60℃で水分8%になるまで乾燥した。次いで、バン
タムミルで粉砕した後、含水率12%まで加湿させ、加
工澱粉(T)を得た。加工澱粉(T)の物性を表3に示
す。
Comparative Example 15 Technology 3 of Japanese Patent Publication No. 46-21472
Performed according to the method described in That is, after water was added to corn starch to make the water content 25%, a roll mill (manufactured by Noritake Company, NR-42A) was ground three times and dried with a hot air dryer at 60 ° C. until the water content became 8%. Next, after pulverizing with a bantam mill, the mixture was humidified to a water content of 12% to obtain a modified starch (T). Table 3 shows the physical properties of the processed starch (T).

【0056】[0056]

【比較例16】特開昭60−233019号公報の例2
に準じた方法で行った。即ち、コーンスターチ1kgを
水1.5kgに分散させ、2.5gの塩化カルシウム加
える。希水酸化ナトリウム溶液を加えることで、pHを
6.0〜6.5に調製する。4%α−アミラーゼ(関東
化学(株)製)溶液250mlを加えた後、55℃に昇
温し、4時間反応させる。次いで希塩酸でpHを2〜3
にし、15分間保った後再び希水酸化ナトリウムを添加
し、pHを約6とする。残渣を濾過洗浄した後、熱風乾
燥機で乾燥し、バンタムミルで粉砕し、加工澱粉(U)
を得た。加工澱粉(U)の物性を表3に示す。
Comparative Example 16 Example 2 of JP-A-60-2333019
Performed according to the method described in That is, 1 kg of corn starch is dispersed in 1.5 kg of water, and 2.5 g of calcium chloride is added. The pH is adjusted to 6.0-6.5 by adding dilute sodium hydroxide solution. After adding 250 ml of a 4% α-amylase (manufactured by Kanto Chemical Co., Ltd.) solution, the temperature is raised to 55 ° C., and the reaction is carried out for 4 hours. Then adjust the pH to 2-3 with dilute hydrochloric acid.
After maintaining for 15 minutes, dilute sodium hydroxide is added again to adjust the pH to about 6. After the residue is filtered and washed, it is dried with a hot air drier, pulverized with a bantam mill, and processed starch (U)
I got Table 3 shows the physical properties of the processed starch (U).

【0057】[0057]

【比較例17】市販品スターチ1500(日本カラコン
(株)製)を加工澱粉(V)とする。加工澱粉(V)の
物性を表3に示す。
Comparative Example 17 A commercially available starch 1500 (manufactured by Nippon Colorcon Co., Ltd.) is used as processed starch (V). Table 3 shows the physical properties of the processed starch (V).

【0058】[0058]

【比較例18】市販品PCS(旭化成工業(株)製)を
加工澱粉(W)とする。加工澱粉(W)の物性を表3に
示す。
Comparative Example 18 A commercially available product PCS (manufactured by Asahi Kasei Kogyo Co., Ltd.) is used as a processed starch (W). Table 3 shows the physical properties of the processed starch (W).

【0059】[0059]

【実施例17】L−アスコルビン酸(武田薬品工業
(株)製)495gと加工澱粉(L)500部を混合
し、次いでステアリン酸マグネシウム5部を混合し、実
施例6と同様に打錠し、錠剤を得た。錠剤物性を表4に
示す。
Example 17 495 g of L-ascorbic acid (manufactured by Takeda Pharmaceutical Co., Ltd.) and 500 parts of modified starch (L) were mixed, and then 5 parts of magnesium stearate were mixed. , Tablets were obtained. Table 4 shows the physical properties of the tablets.

【0060】[0060]

【実施例18】加工澱粉(N)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
Example 18 Example 1 except that modified starch (N) was used.
The same operation as in 7 was performed. Table 4 shows the physical properties of the tablets.

【0061】[0061]

【実施例19】加工澱粉(O)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
Example 19 Example 1 except that modified starch (O) was used.
The same operation as in 7 was performed. Table 4 shows the physical properties of the tablets.

【0062】[0062]

【実施例20】加工澱粉(R)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
Example 20 Example 1 except that modified starch (R) was used.
The same operation as in 7 was performed. Table 4 shows the physical properties of the tablets.

【0063】[0063]

【実施例21】加工澱粉(S)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
Example 21 Example 1 except that modified starch (S) was used.
The same operation as in 7 was performed. Table 4 shows the physical properties of the tablets.

【0064】[0064]

【比較例19】加工澱粉(M)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
Comparative Example 19 Example 1 except that the modified starch (M) was used.
The same operation as in 7 was performed. Table 4 shows the physical properties of the tablets.

【0065】[0065]

【比較例20】加工澱粉(P)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
Comparative Example 20 Example 1 except that modified starch (P) was used.
The same operation as in 7 was performed. Table 4 shows the physical properties of the tablets.

【0066】[0066]

【比較例21】加工澱粉(Q)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
Comparative Example 21 Example 1 except that modified starch (Q) was used.
The same operation as in 7 was performed. Table 4 shows the physical properties of the tablets.

【0067】[0067]

【比較例22】加工澱粉(T)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
Comparative Example 22 Example 1 except that the modified starch (T) was used.
The same operation as in 7 was performed. Table 4 shows the physical properties of the tablets.

【0068】[0068]

【比較例23】加工澱粉(U)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
Comparative Example 23 Example 1 except that modified starch (U) was used.
The same operation as in 7 was performed. Table 4 shows the physical properties of the tablets.

【0069】[0069]

【比較例24】加工澱粉(V)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
Comparative Example 24 Example 1 except that modified starch (V) was used.
The same operation as in 7 was performed. Table 4 shows the physical properties of the tablets.

【0070】[0070]

【比較例25】加工澱粉(W)を用いる以外は実施例1
7と同様に操作した。錠剤物性を表4に示す。
Comparative Example 25 Example 1 except that modified starch (W) was used.
The same operation as in 7 was performed. Table 4 shows the physical properties of the tablets.

【0071】[0071]

【実施例22】加工澱粉(B)400g、アスピリン
(保栄薬工(株)製)400g、200メッシュ乳糖
(DMV社製)190gを混合し、さらにステアリン酸
マグネシウム10gを加えて混合する。次に、混合した
粉体をローラーコンパクター・ミニ(フロイント産業
(株)製)を用いて、2トンの圧力で板上に圧縮した
後、解砕した。次いで、解砕物を篩分して、12メッシ
ュ(目開き1410μm)を通過し、80メッシュ(目
開き180μm)に残留する顆粒を、ロータリー打錠機
を用いて実施例6と同様に打錠し、錠剤を得た。錠剤物
性を表5に示す。
Example 22 400 g of processed starch (B), 400 g of aspirin (manufactured by Hoei Pharmaceutical Co., Ltd.) and 190 g of lactose 200 mesh (manufactured by DMV) are mixed, and 10 g of magnesium stearate is further added and mixed. Next, the mixed powder was compressed on a plate with a pressure of 2 tons using a roller compactor mini (manufactured by Freund Corporation) and then crushed. Next, the pulverized product was sieved, passed through 12 mesh (aperture 1410 μm), and granules remaining in an 80 mesh (aperture 180 μm) were tableted in the same manner as in Example 6 using a rotary tableting machine. , Tablets were obtained. Table 5 shows the physical properties of the tablets.

【0072】[0072]

【実施例23】加工澱粉(N)を用いる以外は実施例2
2と同様に操作した。錠剤物性を表5に示す。
Example 23 Example 2 except that modified starch (N) was used.
The operation was the same as in 2. Table 5 shows the physical properties of the tablets.

【0073】[0073]

【比較例26】加工澱粉(C)を用いる以外は実施例2
2と同様に操作した。錠剤物性を表5に示す。
Comparative Example 26 Example 2 except that modified starch (C) was used.
The operation was the same as in 2. Table 5 shows the physical properties of the tablets.

【0074】[0074]

【比較例27】加工澱粉(T)を用いる以外は実施例2
2と同様に操作した。錠剤物性を表5に示す。
Comparative Example 27 Example 2 except that the modified starch (T) was used.
The operation was the same as in 2. Table 5 shows the physical properties of the tablets.

【0075】[0075]

【比較例28】加工澱粉(U)を用いる以外は実施例2
2と同様に操作した。錠剤物性を表5に示す。
Comparative Example 28 Example 2 except that modified starch (U) was used.
The operation was the same as in 2. Table 5 shows the physical properties of the tablets.

【0076】[0076]

【表1】 [Table 1]

【0077】[0077]

【表2】 [Table 2]

【0078】[0078]

【表3】 [Table 3]

【0079】[0079]

【表4】 [Table 4]

【0080】[0080]

【表5】 [Table 5]

【0081】[0081]

【発明の効果】特定された物性を持つことにより、結合
性と崩壊性の両機能を同時に併せ持つ加工澱粉を用い
て、直接打錠あるいは乾式顆粒法で製剤すると、結合性
に優れるため、錠剤硬度あるいは顆粒強度の高い製剤が
できる。また、同時に崩壊性にも優れるので、その製剤
は投与後、迅速な崩壊を示し、薬物の溶出速度が早くな
る。以上、加工澱粉が結合性と崩壊性の両機能を持つた
め、処方を簡潔にできること、薬物に対する安定性が高
いことなどにより、品質設計が容易になる。
According to the present invention, when a processed starch having both the binding property and the disintegration function at the same time and having the specified physical properties is used, and the product is formulated by direct compression or dry granulation, the binding property is excellent. Alternatively, a preparation having high granule strength can be obtained. At the same time, since the preparation is excellent in disintegration, the preparation shows rapid disintegration after administration, and the dissolution rate of the drug is increased. As described above, since the processed starch has both functions of binding and disintegration, the quality can be easily designed by simplifying the formulation and having high stability to drugs.

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 生澱粉を水分の存在下、加熱処理するこ
とにより得られる加工澱粉であって、含水率が8〜15
%、冷水可溶分が10%未満、膨潤容積が5〜15ml
/gであって、実質的に澱粉粒子が破壊されることなく
澱粉の粒子形態を維持しており、非複屈折性を示す粒子
が複屈折性を示す粒子より多く存在することを特徴とす
結合性、崩壊性に優れる加工澱粉。
1. A modified starch obtained by subjecting raw starch to heat treatment in the presence of water, wherein the starch has a water content of 8 to 15%.
%, Soluble in cold water is less than 10%, swelling volume is 5 to 15 ml
/ G without substantially destroying the starch particles
Non-birefringent particles that maintain starch particle morphology
Are present more than particles exhibiting birefringence.
Binding, processed starch having excellent disintegration property that.
【請求項2】 請求項1に記載の加工澱粉を含有するこ
とを特徴とする製剤組成物。
2. A pharmaceutical composition comprising the modified starch according to claim 1.
JP3085426A 1991-04-17 1991-04-17 Processed starch with excellent binding and disintegration properties Expired - Lifetime JP3004758B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3085426A JP3004758B2 (en) 1991-04-17 1991-04-17 Processed starch with excellent binding and disintegration properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3085426A JP3004758B2 (en) 1991-04-17 1991-04-17 Processed starch with excellent binding and disintegration properties

Publications (2)

Publication Number Publication Date
JPH04318001A JPH04318001A (en) 1992-11-09
JP3004758B2 true JP3004758B2 (en) 2000-01-31

Family

ID=13858507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3085426A Expired - Lifetime JP3004758B2 (en) 1991-04-17 1991-04-17 Processed starch with excellent binding and disintegration properties

Country Status (1)

Country Link
JP (1) JP3004758B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009123102A1 (en) 2008-03-31 2009-10-08 旭化成ケミカルズ株式会社 Processed starch powder with excellent disintegration properties and manufacturing method thereof

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914936D0 (en) * 1999-06-26 1999-08-25 Cerestar Holding Bv Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets
WO2005005484A1 (en) * 2003-07-11 2005-01-20 Asahi Kasei Chemicals Corporation Functional starch powder
US8871270B2 (en) * 2004-07-09 2014-10-28 Corn Products Development, Inc Tablet excipient
JP4753567B2 (en) * 2004-11-19 2011-08-24 旭化成ケミカルズ株式会社 Method for producing tablet containing highly adhesive drug
JP2007001999A (en) * 2005-06-21 2007-01-11 Asahi Kasei Chemicals Corp Method for producing granule composition
WO2007055329A1 (en) 2005-11-11 2007-05-18 Asahi Kasei Chemicals Corporation Controlled release solid preparation
EP2062599A4 (en) * 2006-09-14 2013-03-27 Astellas Pharma Inc Orally disintegrating tablet and process for production thereof
US7994183B2 (en) * 2007-03-13 2011-08-09 Takeda Pharmaceutical Company Limited Solid preparation comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile
JP2015218322A (en) * 2014-05-21 2015-12-07 旭化成ケミカルズ株式会社 Fine starch particle and production method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009123102A1 (en) 2008-03-31 2009-10-08 旭化成ケミカルズ株式会社 Processed starch powder with excellent disintegration properties and manufacturing method thereof
US8431618B2 (en) 2008-03-31 2013-04-30 Asahi Kasei Chemicals Corporation Processed starch powder with excellent disintegration properties and manufacturing method thereof
JP5577241B2 (en) * 2008-03-31 2014-08-20 旭化成ケミカルズ株式会社 Processed starch powder with excellent disintegration and process for producing the same

Also Published As

Publication number Publication date
JPH04318001A (en) 1992-11-09

Similar Documents

Publication Publication Date Title
KR960009182B1 (en) Pharmaceutical tablet and granulate and process for their preparation
CA2414945C (en) Cellulose powder
US5888548A (en) Spherically agglomerated starches with silicon dioxide
US4369308A (en) Low swelling starches as tablet disintegrants
US4533674A (en) Process for preparing a sugar and starch free spray-dried vitamin C powder containing 90 percent ascorbic acid
US4383111A (en) Processed starch, process for preparing same and use of same in medicines
CA1267843A (en) Process for preparing sucrose encrusted methylcellulose particles for use in bulk laxative compositions
JP6706245B2 (en) Directly compressible composition containing microcrystalline cellulose
JPH06500576A (en) controlled release verapamil tablets
JP3004758B2 (en) Processed starch with excellent binding and disintegration properties
US5651988A (en) Combination osmotic and bulk forming laxatives
JP3212534B2 (en) Low substituted hydroxypropylcellulose powder
EP1192942B1 (en) Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose
US5985323A (en) Microcrystalline cellulose/alginate wet granulation excipient/binder
WO2008059652A1 (en) Disintegrating agent, and tablet and granule each containing the same
JP4774739B2 (en) Kampo extract-containing tablet composition and method for producing the same
JPH0912426A (en) Hygroscopic material composition
JPH04128221A (en) Analgesic composition and its composition
EP1319670A1 (en) Low-substituted hydroxypropyl cellulose
JP2001181195A (en) Solid preparation containing tetousutore extract as active ingredient
JPS6354693B2 (en)
JP3310233B2 (en) Disintegrant for tablets
JP2007001875A (en) Method for producing granule composition
JPS59193815A (en) Preparation of tablet
JPH07277978A (en) Nifedipine solid particle composition for tablet production

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19991102

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081119

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081119

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091119

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091119

Year of fee payment: 10

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091119

Year of fee payment: 10

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101119

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101119

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111119

Year of fee payment: 12

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111119

Year of fee payment: 12